Research
Hormonal
Semaglutide shows effective weight reduction and HbA1c lowering in Type 2 Diabetes treatment.
Semaglutide can be recommended for patients with Type 2 Diabetes who also need to lose weight.
StrongSupportsmedium confidence
Semaglutid ist bereits als GLP-1RA zur Therapie des Typ 2 Diabetes zugelassen und zeigt, neben einer effektiven HbA1c-Senkung, eine deutliche Gewichtsreduktion.
Why this rating
The claim is based on established clinical outcomes for Semaglutide.
Source
Medikamentöse Adipositastherapie – Chancen und Perspektiven
Anne Lautenbach et al. · Adipositas - Ursachen Folgeerkrankungen Therapie · 2021
reviewCited 2×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →